Form 8-K - Current report:
SEC Accession No. 0001104659-17-071462
Filing Date
2017-12-01
Accepted
2017-12-01 17:13:31
Documents
3
Period of Report
2017-12-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-27875_18k.htm 8-K 25219
2 EX-99.1 a17-27875_1ex99d1.htm EX-99.1 16537
3 GRAPHIC g278751mmi001.jpg GRAPHIC 2866
  Complete submission text file 0001104659-17-071462.txt   47051
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 171234872
SIC: 2834 Pharmaceutical Preparations